Show simple item record

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

dc.contributor.authorPorsbjerg, Celeste M.
dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorTran, Trung N
dc.contributor.authorMurray, Ruth B
dc.contributor.authorUnni, Bindhu
dc.contributor.authorAng, Shi Ling Audrey
dc.contributor.authorAlacqua, Marianna
dc.contributor.authorAl-Ahmad, Mona
dc.contributor.authorAl-Lehebi, Riyad
dc.contributor.authorAltraja, Alan
dc.contributor.authorBelevskiy, Andrey S.
dc.contributor.authorBjörnsdóttir, Unnur S.
dc.contributor.authorBourdin, Arnaud
dc.contributor.authorBusby, John
dc.contributor.authorWalter Canonica, G
dc.contributor.authorChristoff, George
dc.contributor.authorCosio, Borja G.
dc.contributor.authorCostello, Richard W
dc.contributor.authorFitzGerald, J. Mark
dc.contributor.authorFonseca, João A.
dc.contributor.authorHansen, Susanne
dc.contributor.authorHeaney, Liam G
dc.contributor.authorHeffler, Enrico
dc.contributor.authorHew, Mark
dc.contributor.authorIwanaga, Takashi
dc.contributor.authorJackson, David J
dc.contributor.authorKocks, Janwillem W H
dc.contributor.authorKallieri, Maria
dc.contributor.authorBruce Ko, Hsin-Kuo
dc.contributor.authorSiyue, Mariko Koh
dc.contributor.authorLarenas-Linnemann, Désirée
dc.contributor.authorLehtimäki, Lauri A.
dc.contributor.authorLoukides, Stelios
dc.contributor.authorLugogo, Njira
dc.contributor.authorMaspero, Jorge F
dc.contributor.authorPapaioannou, Andriana I.
dc.contributor.authorPerez de Llano, Luis
dc.contributor.authorMárcio Pitrez , Paulo
dc.contributor.authorPopov, Todor A
dc.contributor.authorRasmussen, Linda M.
dc.contributor.authorRhee, Chin Kook
dc.contributor.authorSadatsafavi, Mohsen
dc.contributor.authorSchmidt, Johannes
dc.contributor.authorSiddiqui, Salman
dc.contributor.authorTaillé, Camille
dc.contributor.authorTaube, Christian
dc.contributor.authorTorres-Duque, Carlos A.
dc.contributor.authorUlrik, Charlotte
dc.contributor.authorUpham, John W
dc.contributor.authorEileen, Wang
dc.contributor.authorWechsler, Michael E
dc.contributor.authorBulathsinhala, Lakmini
dc.contributor.authorCarter, Victoria
dc.contributor.authorChaudhry, Isha
dc.contributor.authorEleangovan, Nevaashni
dc.contributor.authorHosseini, Naeimeh
dc.contributor.authorRowlands, Mari-Anne
dc.contributor.authorPrice, David
dc.contributor.authorvan Boven, Job FM
dc.date.accessioned2023-07-28T23:06:22Z
dc.date.available2023-07-28T23:06:22Z
dc.date.issued2022-05
dc.identifier209819492
dc.identifierd032fef9-1eac-4d97-9c34-ca0c60394b2b
dc.identifier85124182218
dc.identifier.citationPorsbjerg , C M , Menzies-Gow , A , Tran , T N , Murray , R B , Unni , B , Ang , S L A , Alacqua , M , Al-Ahmad , M , Al-Lehebi , R , Altraja , A , Belevskiy , A S , Björnsdóttir , U S , Bourdin , A , Busby , J , Walter Canonica , G , Christoff , G , Cosio , B G , Costello , R W , FitzGerald , J M , Fonseca , J A , Hansen , S , Heaney , L G , Heffler , E , Hew , M , Iwanaga , T , Jackson , D J , Kocks , J W H , Kallieri , M , Bruce Ko , H-K , Siyue , M K , Larenas-Linnemann , D , Lehtimäki , L A , Loukides , S , Lugogo , N , Maspero , J F , Papaioannou , A I , Perez de Llano , L , Márcio Pitrez , P , Popov , T A , Rasmussen , L M , Rhee , C K , Sadatsafavi , M , Schmidt , J , Siddiqui , S , Taillé , C , Taube , C , Torres-Duque , C A , Ulrik , C , Upham , J W , Eileen , W , Wechsler , M E , Bulathsinhala , L , Carter , V , Chaudhry , I , Eleangovan , N , Hosseini , N , Rowlands , M-A , Price , D & van Boven , J FM 2022 , ' Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma ' , The Journal of Allergy and Clinical Immunology: In Practice , vol. 10 , no. 5 . https://doi.org/10.1016/j.jaip.2021.12.027en
dc.identifier.issn2213-2198
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19690
dc.descriptionFunding: This research study was funded and delivered by the Observational & Pragmatic Research Institute Pte Ltd (OPRI). The International Severe Asthma Registry is co-funded by Optimum Patient Care Global Limited and AstraZeneca.en
dc.format.extent1821279
dc.format.extent14021350
dc.language.isoeng
dc.relation.ispartofThe Journal of Allergy and Clinical Immunology: In Practiceen
dc.subjectsevere asthmaen
dc.subjectBiologics accessen
dc.subjectBiologic eligibilityen
dc.subjectR Medicineen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleGlobal Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthmaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1016/j.jaip.2021.12.027


Files in this item

Thumbnail
Name:
Campano_etal_CDSR_Marine_Deriv ...
Size:
1.007Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record